The ASO is designed to bind and increase the exon 7 inclusion of SMN2, which can produce elevated levels of functional SMN protein to compensate for the loss of SMN1, the cause of SMA (Hua et al, 2010; Hua et al, 2007; Rigo et al, 2012). Here, SMN2 is linked to proximal spinal muscular atrophy.